Other News

AI That Sees the Invisible: AliveCor and Mayo Clinic Announce Collaboration to Develop Groundbreaking AI Technology to Help Prevent Sudden Cardiac Death

AliveCor Press Release July 19, 2017 – Mountain View, CA – AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced a collaboration with Mayo Clinic to develop tools for medical and non-medical personnel to easily screen for long QT syndrome (LQTS) early by combining AliveCor’s AI technology with […]

ClearFlow Expands Distribution Of Pleuraflow System For Pediatric Cardiothoracic Surgery

ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, has announced a full market release for the 20Fr SEDL version of the PleuraFlow® Active Clearance Technology® System for the treatment of pediatric cardiothoracic surgery patients. The SEDL refers to the “shorter effective drainage length,” which facilitates placement of the […]

Cardiac Science (CSCX) Release: Canadian Regulatory Authority Approves Powerheart G5 Automatic AED

DEERFIELD, Wis., July 20, 2017 /PRNewswire/ — Cardiac Science, a leading global manufacturer of potentially life-saving automated external defibrillators (AEDs), announced today that it has been granted approval by the Canadian regulatory agency, Health Canada, to begin marketing its fully automatic Powerheart® G5 AED in Canada. The approval represents a milestone for Cardiac Science […]

CV Sciences, Inc. Cites Recent Clinical Study On Pharmaceutical-Grade CBD Shown To Lower Blood Pressure

Company Gaining Traction with Drug Candidate CVSI-007 to Become the Only FDA Approved Treatment for Smokeless Tobacco Addiction LAS VEGAS, NV–(Marketwired – July 20, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), highlights a recent clinical study using pharmaceutical grade cannabidiol (CBD) which suggests that CBD […]

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

LAKE OSWEGO, Ore., July 19, 2017 /PRNewswire/ — BIOTRONIK today announced FDA approval and availability of the Intica DX and Intica cardiac resynchronization therapy (CRT)-DX implantable cardioverter defibrillator (ICD) systems. The launch of Intica CRT-DX extends the proven benefits of BIOTRONIK’s DX technology to heart failure patients. DX eliminates the need for an atrial […]

AtriCure (ATRC) Announces Hiring Of Chief Technology Officer

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has hired Salvatore (Sam) Privitera as its Chief Technology Officer. Mr. Privitera will have responsibility for Research and Development activities, as well as Operations, including manufacturing, […]

Should We Be Warning Teenagers Against Using Energy Drinks?

By Ken Dropkiewski (ken@prime-core.com) In a recent randomized study, researchers determined patients with familial long QT syndrome are susceptible to an increase in symptoms ranging from rapid and irregular heart rate to sudden death just from drinking heavily caffeinated energy drinks. As reported in the International Journal of Cardiology, researchers […]

Fiber Endoscope Imaging Developer VerAvanti Raises $5M

Cardiac imaging dev VerAvanti raises $5m JULY 18, 2017 BY FINK DENSFORD, MassDevice Previously-stealthy cardiac imaging developer VerAvanti said today it raised $5 million in a recent round of financing to support its Scanning Fiber Endoscope device development. The Redmond, Wash.-based company’s SFE device uses technology licensed from the University of Washington and consists […]

Angiolite BTK, below the knee sirolimus-eluting stent, changed CE Mark Approval

(BTK), improving blood flow in severe claudication and critical limb ischaemia. Angiolite BTK design has been specifically elaborated for drug eluting stent and benefits from iVascular proprietary coating nanotechnology that yields a multilayer thin coating with optimal kinetics. “Having the right bail-out options, when performing BTK angioplasty, is extremely important in […]

Hope of a New Future for Patients with Heart Failure Using New Implantable Hemodynamic Monitoring Technologies, is Highlighted in New Issue of the Journal of the American College of Cardiology

TEL AVIV, Israel–(BUSINESS WIRE)–A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current and next-generation implantable hemodynamic monitors and how new approaches focused on the direct measurement of left atrial pressure (LAP), seek to expand the use of pressure-guided congestive heart failure […]